Abilify
| Generic Name: | aripiprazole |
| Company: | Bristol-Myers Squibb Company |
| Web Site: | www.abilify.com |
| Country: | USA |
| |
 |
Description: |
Aripiprazole is a psychotropic drug that is available as Abilify (aripiprazole) Tablets,
Abilify Discmelt (aripiprazole) Orally Disintegrating Tablets, Abilify (aripiprazole) Oral
Solution, and Abilify (aripiprazole) Injection, a solution for intramuscular injection. |
| |
| Indications: | Abilify is an atypical antipsychotic indicated as oral formulations for:
1. Treatment of Schizophrenia in adults and adolescents aged 13 to 17 years
2. Treatment of manic or mixed episodes associated with Bipolar I Disorder as monotherapy or adjunctive to lithium or valproate in adults and pediatric patients aged 10 to 17 years
3. Adjunctive treatment of Major Depressive Disorder in adults
Abilify is an atypical antipsychotic indicated as an injection for:
1. Treatment of adults with agitation associated with Schizophrenia or Bipolar I Disorder, manic or mixed episodes
Revised April 2009 |
| |
| |
| |
|
|
|
|
Additional Information
Medications for
Mental Illness
Your Child
and Medications
Bipolar
Disorder
Schizophrenia
Guide
Depression
|
